MIURA Katsuhiro
| Department of Medicine | Associate Professor |
Researcher Information
Research activity information
Paper
- ★Consolidation with 90Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma
Katsuhiro Miura; Hideki Tsujimura; Yasufumi Masaki; Masaki Iino; Jun Takizawa; Yoshinobu Maeda; Kazuhiko Yamamoto; Shinobu Tamura; Akiyo Yoshida; Hideo Yagi; Isao Yoshida; Koichi Kitazume; Taro Masunari; Ilseung Choi; Yasutaka Kakinoki; Ritsuro Suzuki; Tadashi Yoshino; Shigeo Nakamura; Yoshihiro Hatta; Takashi Yoshida; Masatoshi Kanno
Hematological Oncology, Sep. 2020, Refereed, Not invited
Lead - Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.
Noriyoshi Iriyama; Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
Leukemia & lymphoma, Jan. 2023 - [Thrombotic microangiopathy with gastrointestinal hemorrhage during carfilzomib therapy for multiple myeloma].
Shuhei Matsumoto; Hiromichi Takahashi; Takashi Hamada; Katsuhiro Miura; Masaru Nakagwa; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Kazuhide Iizuka; Noriyoshi Iriyama; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2023 - Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.
Takashi Hamada; Hiromichi Takahashi; Masaru Nakagawa; Hironao Nukariya; Shun Ito; Toshihide Endo; Kazuya Kurihara; Takashi Koike; Kazuhide Iizuka; Shimon Ohtake; Takashi Ichinohe; Toshiya Maebayashi; Katsuhiro Miura; Yoshihiro Hatta; Hideki Nakamura
Case reports in oncology, 2023 - Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study.
Hiromichi Takahashi; Katsuhiro Miura; Masaru Nakagawa; Haruna Nishimaki; Shun Ito; Hironao Nukariya; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Takashi Hamada; Kazuhide Iizuka; Shimon Ohatake; Noriyoshi Iriyama; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
Hematological oncology, Dec. 2022 - Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Takashi Hamada; Yoshihito Uchino; Kazuhide Iizuka; Shimon Ohtake; Noriyoshi Iriyama; Yoshihiro Hatta; Hideki Nakamura
Expert review of anticancer therapy, Jun. 2022 - Clinical impact of central nervous system-directed therapies on intravascular large B-cell lymphoma: A single institution's experience.
Hiromichi Takahashi; Haruna Nishimaki; Yoko Nakanishi; Takashi Hamada; Masaru Nakagawa; Kazuhide Iizuka; Yoshihito Uchino; Noriyoshi Iriyama; Katsuhiro Miura; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
EJHaem, May 2022 - Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.
Noriyoshi Iriyama; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Tomohiro Nakayama; Masami Takei; Yoshihiro Hatta; Hideki Nakamura
Chemotherapy, Nov. 2021 - Efficacy of introducing electronic cigarettes in smoker's polycythemia(和訳中)
飯塚 和秀; 伊藤 駿; 忽滑谷 寛直; 遠藤 聖英; 栗原 一也; 小池 隆; 濱田 高志; 中川 優; 内野 慶人; 高橋 宏通; 三浦 勝浩; 入山 規良; 八田 善弘; 中山 智祥; 武井 正美
日本血液学会学術集会, Sep. 2021 - 新規治療薬時代以降に診断された多発性骨髄腫患者における治療モダリティーと予後の変遷
吉田 努; 入山 規良; 内野 慶人; 高橋 宏通; 中川 優; 濱田 高志; 飯塚 和秀; 小池 隆; 栗原 一也; 遠藤 聖英; 野口 夕利花; 三浦 勝浩; 八田 善弘; 中山 智祥; 武井 正美
日大医学雑誌, Feb. 2021 - Absolute Lymphocyte Counts After Lenalidomide Initiation may Predict the Prognosis of Patients With Relapsed or Refractory Multiple Myeloma.
Masaru Nakagawa; Noriyoshi Iriyama; Takuto Ishikawa; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Takashi Hamada; Kazuhide Iizuka; Takashi Koike; Kazuya Kurihara; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
Cancer diagnosis & prognosis, 2021 - Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple Myeloma.
Yurika Noguchi; Noriyoshi Iriyama; Hiromichi Takahashi; Yoshihito Uchino; Masaru Nakagawa; Takashi Hamada; Kazuhide Iizuka; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tsutomu Yoshida; Katsuhiro Miura; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
Cancer diagnosis & prognosis, 2021 - Correlation between alterations in blood flow of malignant lymphomas after induction chemotherapies and clinical outcomes: a pilot study utilising contrast-enhanced ultrasonography for early interim evaluation of lymphoma treatment
Clinical Radiology, 2021, Refereed, Not invited
Corresponding - Personalized patient care with aggressive hematological malignancies in non-responders to first-line treatment
Expert Review of Precision Medicine and Drug Development, 2021, Refereed, Invited
Lead - 難治性免疫・アレルギー疾患の病態の解明と新規治療法の開発
岡山 吉道; 佐野 有隆; 豊島 翔太; 三木 寿美; 武富 芳隆; 坂本 朋美; 李 賢鎬; 齋藤 修; 村上 誠; 田杭 真帆; 伊東 真奈; 遠藤 嵩大; 丹羽 悠介; 葉山 惟大; 藤田 秀樹; 高橋 宏通; 三浦 勝浩; 濱田 岳志; 中川 優; 飯塚 和秀; 内野 慶人; 入山 規良; 小池 隆; 栗原 一也; 都築 広; 長澤 洋介; 長塚 靖子; 岩田 光浩; 北村 登; 丸岡 秀一郎; 福田 麻佐美; 山田 志保; 黒澤 雄介; 伊藤 亮治; 八田 善弘; 中山 智祥; 武井 正美; 徳橋 泰明; 權 寧博; 照井 正
日本大学医学部総合医学研究所紀要, Dec. 2020 - Combined resection of the hepatic artery without reconstruction in pancreaticoduodenectomy: a case report of pancreatic cancer with an aberrant hepatic artery
Surgical Case Reports, Sep. 2020, Refereed, Not invited
Last - Identification of a novel ACVRL1 gene mutation (c.100T>A, p.Cys34Ser) in a Japanese patient with possible hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)
Hiroshi Umemura; Katsuhiro Miura; Hiromu Naruse; Yoshihiro Hatta; Masami Takei; Tomohiro Nakayama
Acta Medica Okayama, Apr. 2020, Refereed, Not invited - びまん性大細胞型B細胞リンパ腫への形質転換をきたしたCD5陽性節性濾胞辺縁帯リンパ腫
小池 隆; 入山 規良; 中川 優; 高橋 宏通; 濱田 高志; 内野 慶人; 三浦 勝浩; 八田 善弘; 中山 智祥; 武井 正美
臨床血液, Mar. 2020 - Increased Arbekacin Clearance in Patients With Febrile Neutropenia.
Takahiro Nakayama; Masayuki Chuma; Naohiro Tochikura; So Iwabuchi; Shinichiro Suzuki; Chiaki Matsumoto; Toru Imai; Takashi Hamada; Masaru Nakagawa; Hiromichi Takahashi; Yoshihito Uchino; Katsuhiro Miura; Noriyoshi Iriyama; Yoshihiro Hatta; Masami Takei; Takahisa Kimura
Therapeutic drug monitoring, Feb. 2020, Refereed, Not invited
Corresponding - [Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma].
Takashi Koike; Noriyoshi Iriyama; Masaru Nakagawa; Hiromichi Takahashi; Takashi Hamada; Yoshihito Uchino; Katsuhiro Miura; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2020 - 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome.
Yasufumi Masaki; Hiroshi Kawabata; Kazue Takai; Norifumi Tsukamoto; Shino Fujimoto; Yasuhito Ishigaki; Nozomu Kurose; Katsuhiro Miura; Shigeo Nakamura; Sadao Aoki
International journal of hematology, Jan. 2020, Refereed, Not invited - Aggressive CD4-CD8-CD45RA+CCR10- Primary Cutaneous Peripheral T-cell Lymphoma, Not Otherwise Specified: A Case Report.
Natsumi Ikumi; Hideki Fujita; Tadashi Terui; Hiromichi Takahashi; Katsuhiro Miura; Yoshihiro Hatta; Masami Takei
Acta dermato-venereologica, Nov. 2019, Refereed, Not invited - Successful management of a patient with multiple nucleos(t)ide analogue-resistant hepatitis B virus and diffuse large B cell lymphoma using tenofovir disoproxil fumarate: a case report.
Mizutani T; Matsuoka S; Kikuta D; Hayama J; Nagai S; Matsumoto N; Nakamura H; Nirei K; Kanda T; Moriyama M; Miura K; Takei M; Sugitani M
Journal of Nihon University Medical Association., Oct. 2019, Refereed, Not invited - MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapy.
Kazuya Kurihara; Noriyoshi Iriyama; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
Medical oncology (Northwood, London, England), Jul. 2019, Refereed, Not invited - A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
Noriyoshi Iriyama; Hiromichi Takahashi; Hiromu Naruse; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
Molecular genetics & genomic medicine, Apr. 2019, Refereed, Not invited - Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
Satoshi Yamasaki; Dai Chihara; Sung-Won Kim; Takahito Kawata; Shuichi Mizuta; Hiroatsu Ago; Takaaki Chou; Takahisa Yamane; Hitoji Uchiyama; Tatsuo Oyake; Katsuhiro Miura; Bungo Saito; Hirofumi Taji; Hirohisa Nakamae; Toshihiro Miyamoto; Takahiro Fukuda; Junya Kanda; Yoshiko Atsuta; Ritsuro Suzuki
International journal of hematology, Feb. 2019, Refereed, Not invited - Regression Of Megathrombocytes After Helicobacter Pylori Eradication: A Case Report
The Internet Journal of Hematology, 2019, Refereed, Not invited - Optimal timing for pegfilgrastim administration in Japanese breast cancer patients receiving intermediate-risk chemotherapies.
Tatsuya Hayama; Kenichi Sakurai; Katsuhiro Miura; Shinsaku Washinosu; Shinya Tsuboi; Akihiro Uchiike; Yoshikazu Yoshida; Masami Takei
International journal of clinical pharmacy, Oct. 2018, Refereed, Not invited
Corresponding - Thrombopoietin Levels During Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia.
Takashi Hamada; Noriyoshi Iriyama; Hiromichi Takahashi; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Yoshihiro Hatta; Masami Takei
Clinical drug investigation, Sep. 2018, Refereed, Not invited - One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
Shimon Ohtake; Hiromichi Takahashi; Masaru Nakagawa; Yoshihito Uchino; Katsuhiro Miura; Noriyoshi Iriyama; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Jul. 2018, Refereed, Not invited - 少量pomalidomideでstringent complete responseに到達した多発性骨髄腫
遠藤聖英; 濱田高志; 大竹志門; 中川 優; 内野慶人; 高橋宏通; 三浦勝浩; 入山規良; 小池 隆; 栗原一也; 佐藤紘子; 八田善弘; 武井正美
臨床血液, May 2018, Refereed, Not invited - Enhanced perforin expression associated with dasatinib therapy in natural killer cells.
Noriyoshi Iriyama; Hiromichi Takahashi; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Yoshihiro Hatta; Masami Takei
Leukemia research, May 2018, Refereed, Not invited - [Achievement of a stringent complete response with low-dose pomalidomide monotherapy in a multiple myeloma patient].
Toshihide Endo; Takashi Hamada; Shimon Otake; Masaru Nakagawa; Yshihito Uchino; Hiromichi Takahashi; Katsuhiro Miura; Noriyoshi Iriyama; Takashi Koike; Kazuya Kurihara; Hiroko Sato; Yoshihiro Hatta; Msamai Takei
[Rinsho ketsueki] The Japanese journal of clinical hematology, 2018 - Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study.
Berend Snijder; Gregory I Vladimer; Nikolaus Krall; Katsuhiro Miura; Ann-Sofie Schmolke; Christoph Kornauth; Oscar Lopez de la Fuente; Hye-Soo Choi; Emiel van der Kouwe; Sinan Gültekin; Lukas Kazianka; Johannes W Bigenzahn; Gregor Hoermann; Nicole Prutsch; Olaf Merkel; Anna Ringler; Monika Sabler; Georg Jeryczynski; Marius E Mayerhoefer; Ingrid Simonitsch-Klupp; Katharina Ocko; Franz Felberbauer; Leonhard Müllauer; Gerald W Prager; Belgin Korkmaz; Lukas Kenner; Wolfgang R Sperr; Robert Kralovics; Heinz Gisslinger; Peter Valent; Stefan Kubicek; Ulrich Jäger; Philipp B Staber; Giulio Superti-Furga
The Lancet. Haematology, Dec. 2017, Refereed, Not invited - Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib.
Noriyoshi Iriyama; Katsuhiro Miura; Yoshihiro Hatta; Sumiko Kobayashi; Yoshihito Uchino; Daisuke Kurita; Hitomi Sakagami; Hiromichi Takahashi; Masashi Sakagami; Yujin Kobayashi; Masaru Nakagawa; Shimon Ohtake; Yoshikazu Iizuka; Masami Takei
Oncology letters, May 2017, Refereed, Not invited - A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.
Katsuhiro Miura; Jun Konishi; Takaaki Miyake; Masanori Makita; Atsuko Hojo; Yasufumi Masaki; Masatoshi Uno; Jun Ozaki; Chikamasa Yoshida; Daigo Niiya; Koichi Kitazume; Yoshinobu Maeda; Jun Takizawa; Rika Sakai; Tomofumi Yano; Kazuhiko Yamamoto; Kazutaka Sunami; Yasushi Hiramatsu; Kazutoshi Aoyama; Hideki Tsujimura; Jun Murakami; Yoshihiro Hatta; Masatoshi Kanno
The oncologist, May 2017, Refereed, Not invited
Lead - A clinical prediction model for infusion-related reactions to rituximab in patients with B cell lymphomas.
Tatsuya Hayama; Katsuhiro Miura; Akihiro Uchiike; Masaru Nakagawa; Daisuke Tsutsumi; Masashi Sakagami; Yoshikazu Yoshida; Masami Takei
International journal of clinical pharmacy, Apr. 2017, Refereed, Not invited - Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy
Hiromichi Takahashi; Katsuhiro Miura; Masaru Nakagawa; Masahiko Sugitani; Yusuke Amano; Daisuke Kurita; Masashi Sakagami; Shimon Ohtake; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Sumiko Kobayashi; Atsuko Hojo; Yujin Kobayashi; Yukio Hirabayashi; Machiko Kusuda; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
LEUKEMIA & LYMPHOMA, Dec. 2016, Refereed, Not invited - A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Daisuke Kurita; Kengo Takeuchi; Sumiko Kobayashi; Atsuko Hojo; Yoshihito Uchino; Masashi Sakagami; Shimon Ohtake; Hiromichi Takahashi; Katsuhiro Miura; Noriyoshi Iriyama; Masahiko Sugitani; Hiroaki Miyoshi; Yoshihiro Hatta; Koichi Ohshima; Masami Takei
Virchows Archiv : an international journal of pathology, Oct. 2016, Refereed, Not invited - Plasma cell maturity as a predictor of prognosis in multiple myeloma
Noriyoshi Iriyama; Katsuhiro Miura; Yoshihiro Hatta; Yoshihito Uchino; Daisuke Kurita; Hiromichi Takahashi; Hitomi Sakagami; Masashi Sakagami; Yujin Kobayashi; Masaru Nakagawa; Shimon Ohtake; Yoshikazu Iizuka; Masami Takei
MEDICAL ONCOLOGY, Aug. 2016, Refereed, Not invited - Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.
Yasufumi Masaki; Hiroshi Kawabata; Kazue Takai; Masaru Kojima; Norifumi Tsukamoto; Yasuhito Ishigaki; Nozomu Kurose; Makoto Ide; Jun Murakami; Kenji Nara; Hiroshi Yamamoto; Yoko Ozawa; Hidekazu Takahashi; Katsuhiro Miura; Tsutomu Miyauchi; Shinichirou Yoshida; Akihito Momoi; Nobuyasu Awano; Soichiro Ikushima; Yasunori Ohta; Natsue Furuta; Shino Fujimoto; Haruka Kawanami; Tomoyuki Sakai; Takafumi Kawanami; Yoshimasa Fujita; Toshihiro Fukushima; Shigeo Nakamura; Tomohiro Kinoshita; Sadao Aoki
International journal of hematology, Jun. 2016, Refereed, Not invited - Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy
Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Asami Izu; Masahiko Sugitani; Daisuke Kurita; Masashi Sakagami; Shimon Ohtake; Yoshihito Uchino; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Yujin Kobayashi; Noriyoshi Iriyama; Sumiko Kobayashi; Satomi Kiso; Yukio Hirabayashi; Yoshihiro Hatta; Masami Takei
LEUKEMIA & LYMPHOMA, Jun. 2016, Refereed, Not invited - Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies
Katsuhiro Miura; Masaru Nakagawa; Hiromichi Takahashi; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Masashi Sakagami; Shimon Ohtake; Sumiko Kobayashi; Atsuko Hojo; Daisuke Kurita; Yujin Kobayashi; Machiko Kusuda; Yukio Hirabayashi; Yoshihiro Hatta; Masami Takei
INTERNATIONAL JOURNAL OF HEMATOLOGY, Mar. 2016, Refereed, Not invited - 血液造血器腫瘍における免疫療法の展望
三浦勝浩; 八田善弘; 武井正美
日大医学雑誌, 2016, Not refereed, Not invited - Higher Red Blood Cell Distribution Width Is an Adverse Prognostic Factor in Chronic-phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
Noriyoshi Iriyama; Yoshihiro Hatta; Sumiko Kobayashi; Yoshihito Uchino; Katsuhiro Miura; Daisuke Kurita; Hitomi Kodaira; Hiromichi Takahashi; Yoshikazu Iizuka; Mitsuru Inoue; Masami Takei
ANTICANCER RESEARCH, Oct. 2015, Refereed, Not invited - Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma
Daisuke Kurita; Katsuhiro Miura; Masaru Nakagawa; Shimon Ohtake; Masashi Sakagami; Yoshihito Uchino; Hiromichi Takahashi; Satomi Kiso; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Yukio Hirabayashi; Yujin Kobayashi; Noriyoshi Iriyama; Sumiko Kobayashi; Yoshihiro Hatta; Yoshimasa Kura; Masahiko Sugitani; Masami Takei
INTERNATIONAL JOURNAL OF HEMATOLOGY, Jun. 2015, Refereed, Not invited - Radiation therapy for cutaneous blastic plasmacytoid dendritic cell neoplasm: A case report and review of the literature
Naoya Ishibashi; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Osamu Abe; Katsuhiro Miura; Yoshihiro Hatta; Masahiko Sugitani
International Journal of Clinical and Experimental Medicine, May 2015, Refereed, Not invited - Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma
Yujin Kobayashi; Yoshihiro Hatta; Masahiko Sugitani; Atsuko Hojo; Masaru Nakagawa; Machiko Kusuda; Yoshihito Uchino; Hiromichi Takahashi; Satomi Kiso; Yukio Hirabayashi; Mai Yagi; Hitomi Kodaira; Daisuke Kurita; Katsuhiro Miura; Noriyoshi Iriyama; Sumiko Kobayashi; Yoshimasa Kura; Akira Horikoshi; Umihiko Sawada; Jin Takeuchi; Masami Takei
LEUKEMIA & LYMPHOMA, Nov. 2014, Refereed, Not invited - The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemia
Noriyoshi Iriyama; Yoshihiro Hatta; Sumiko Kobayashi; Yoshihito Uchino; Katsuhiro Miura; Daisuke Kurita; Hitomi Kodaira; Mitsuru Inoue; Masami Takei
INTERNATIONAL JOURNAL OF HEMATOLOGY, Oct. 2014, Refereed, Not invited - Diagnostic value of brain biopsy in intravascular large B-cell lymphoma mimicking progressive multifocal leukoencephalopathy: Case report
Yusuke Takamine; Natsumi Ikumi; Hajime Onoe; Misa Hayase; Yousuke Nagasawa; Masashi Sakagami; Kaita Sugiyama; Suguru Nakahawa; Yoshito Uchino; Hiromichi Takahashi; Yukio Hirabayashi; Takamasa Nozaki; Katsuhiro Miura; Hirotake Inomata; Noriyoshi Iriyama; Hidetaka Shiraiwa; Sumiko Kobayashi; Noboru Kitamura; Yoshihiro Hatta; Yoshihiro Matsukawa; Masami Takei
Japanese Journal of Clinical Immunology, 2014, Refereed, Not invited - Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology
S. W. Kim; S. S. Yoon; R. Suzuki; Y. Matsuno; H. G. Yi; T. Yoshida; M. Imamura; A. Wake; K. Miura; M. Hino; T. Ishikawa; J. S. Kim; Y. Maeda; J. J. Lee; H. J. Kang; H. S. Lee; J. H. Lee; K. Izutsu; T. Fukuda; C. W. Kim; T. Yoshino; K. Ohshima; S. Nakamura; K. Nagafuji; J. Suzumiya; M. Harada; C. S. Kim
Leukemia, Jun. 2013, Refereed, Not invited - Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas
Noriyoshi Iriyama; Hiromichi Takahashi; Yoshihiro Hatta; Katsuhiro Miura; Yujin Kobayashi; Daisuke Kurita; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Satomi Kiso; Yoshihito Uchino; Masaru Nakagawa; Machiko Kusuda; Sumiko Kobayashi; Akira Horikoshi; Yoshimasa Kura; Tetsuo Yamazaki; Umihiko Sawada; Jin Takeuchi
ONCOLOGY REPORTS, Feb. 2013, Refereed, Not invited - Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients
Akira Horikoshi; Noriyoshi Iriyama; Yukio Hirabayashi; Hitomi Kodaira; Yoshihiro Matsukawa; Yoshihito Uchino; Hiromichi Takahashi; Yoshihiro Hatta; Jin Takeuchi; Sumiko Kobayashi; Katsuhiro Miura
Chemotherapy, 2013, Refereed, Not invited - Diagnostic Value of Open Biopsy for Malignant T-Cell Lymphoma of the Liver
Akihisa Hojo; Hisashi Nakayama; Osamu Aramaki; Tokio Higaki; Masamichi Moriguchi; Masahiko Sugitani; Katsuhiro Miura; Jin Takeuchi; Ryu Nishiyama; Mitsuhiko Moriyama; Tadatoshi Takayama
INTERNATIONAL SURGERY, Jan. 2013, Refereed, Not invited - 集学的治療が奏功した原発不明転移性脊椎腫瘍および早期食道がんの重複症例
三浦 勝浩; 平林 幸生; 海老原 貴之; 前林 俊也; 水野 滋章; 山口 太平; 徳橋 泰明; 竹内 仁
日大医学雑誌, Feb. 2012 - Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP
Yujin Kobayashi; Yoshihiro Hatta; Atsuko Hojo; Yoshimasa Kura; Yoshihito Uchino; Hiromichi Takahashi; Satomi Kiso; Yukio Hirabayashi; Mai Yagi; Hitomi Kodaira; Daisuke Kurita; Toshitake Tanaka; Katsuhiro Miura; Noriyoshi Iriyama; Sumiko Kobayashi; Umihiko Sawada; Masahiko Sugitani; Jin Takeuchi
EXPERIMENTAL AND THERAPEUTIC MEDICINE, Feb. 2012, Refereed, Not invited - A Case Series of Bacillus Cereus Septicemia in Patients with Hematological Disease
Yoshihito Uchino; Noriyoshi Iriyama; Ken Matsumoto; Yukio Hirabayashi; Katsuhiro Miura; Daisuke Kurita; Yujin Kobayashi; Mai Yagi; Hitomi Kodaira; Atsuko Hojo; Sumiko Kobayashi; Yoshihiro Hatta; Jin Takeuchi
INTERNAL MEDICINE, 2012, Refereed, Not invited - Efficacy and safety of antifungal prophylaxis with oral itraconazole solution among patients receiving corticosteroids: who should be given prophylaxis?
Noriyoshi Iriyama; Yoshihiro Matsukawa; Katsuhiro Miura; Hirotake Inomata; Yukio Hirabayashi; Yoshihiro Hatta; Akira Horikoshi; Jin Takeuchi
JOURNAL OF INFECTION AND CHEMOTHERAPY, Dec. 2011, Refereed, Not invited - Attenuated immunochemotherapy for diffuse large B-cell lymphoma
Katsuhiro Miura; Yujin Kobayashi; Atsuko Hojo; Yoshihiro Hatta; Jin Takeuchi
LANCET ONCOLOGY, Aug. 2011, Not refereed, Not invited - Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma
Yujin Kobayashi; Katsuhiro Miura; Atsuko Hojo; Yoshihiro Hatta; Toshitake Tanaka; Daisuke Kurita; Noriyoshi Iriyama; Sumiko Kobayashi; Jin Takeuchi
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, Jul. 2011, Refereed, Not invited - An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma
Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Satomi Kiso; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Daisuke Kurita; Yujin Kobayashi; Toshitake Tanaka; Noriyoshi Iriyama; Yoshihiro Hatta; Yoshimasa Kura; Tetsuo Yamazaki; Umihiko Sawada; Jin Takeuchi
INTERNATIONAL JOURNAL OF HEMATOLOGY, Jul. 2011, Refereed, Not invited - Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan
Miura; K.; Takasaki; H.; Tsujimura; H.; Kanno; M.; Maeda; Y.; Tomita; N.; Takai; K.; Masaki; Y.; Takizawa; J.; Mori; H.; Terasaki; Y.; Yoshida; T.; Takeuchi; J. and Motomura; S.
Int J Hematol, May 2011, Not refereed, Not invited
Lead - Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan
Katsuhiro Miura; Hirotaka Takasaki; Hideki Tsujimura; Masatoshi Kanno; Yoshinobu Maeda; Naoto Tomita; Kazue Takai; Yasufumi Masaki; Jun Takizawa; Hiraku Mori; Yasushi Terasaki; Takashi Yoshida; Jin Takeuchi; Shigeki Motomura
INTERNATIONAL JOURNAL OF HEMATOLOGY, May 2011, Refereed, Not invited - A case of aggressive myeloma recognized shortly after the remission following high-dose chemotherapy with autologous peripheral blood stem cell transplantation
Kaname Ueda; Katsuhiro Miura; Yoshihiro Hatta; Sumiko Kobayashi; Toshitake Tanaka; Atsuko Hojo; Hikaru Ishizuka; Umihiko Sawada; Yoshimasa Kura; Jin Takeuchi
International Journal of Hematology, Oct. 2010, Refereed, Not invited - A case of aggressive myeloma recognized shortly after the remission following high-dose chemotherapy with autologous peripheral blood stem cell transplantation Journal: Int J Hematol
Ueda; K.; Miura; K.; Hatta; Y.; Kobayashi; S.; Tanaka; T.; Hojo; A.; Ishizuka; H.; Sawada; U.; Kura; Y. and Takeuchi; J.
Int J Hematol, Oct. 2010, Refereed, Not invited - JALSG AML201試験における急性骨髄性白血病の感染症に関する解析
秋山 暢; 吉田 稔; 三浦 勝浩; 宮武 淳一; 半田 寛; 木藤 克之; 高橋 正知; 重野 一幸; 神田 善伸; 藤田 浩之; 初見 菜穂子; 大西 一功; 宮脇 修一; 大竹 茂樹; 直江 知樹
臨床血液, Sep. 2010, Refereed, Not invited - A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance
Yoshiko Nakagawa; Katsuhiro Miura; Tetsuo Yamazaki; Hikaru Ishizuka; Kazuhiro Takei; Umihiko Sawada; Yoshimasa Kura; Yoshihiro Hatta; Jin Takeuchi
INTERNATIONAL JOURNAL OF HEMATOLOGY, Apr. 2010, Refereed, Not invited - より良い診療を目指して 他診療科との連携 悪性リンパ腫。
三浦勝浩; 竹内 仁
眼科, 2010, Not refereed, Invited - .非ホジキンリンパ腫治療後に急性単球性白血病を合併した１例
杉田馨里奈; 八田善弘; 三浦勝浩; 栗田大輔; 小林優人; 田中稔丈; 石塚光; 竹井和大; 小林寿美子; 相澤信; 杉谷雅彦; 竹内仁
日大医誌, 2010, Refereed, Not invited - Feasibility and eligibility of retreatment with rabbit anti-T lymphocyte globulin for aplastic anemia previously treated with horse anti-thymocyte globulin
Miura; K. Hatta; Y. Kobayashi; S. Iriyama; Y. Takei; K. Takeuchi; J.
Int J Hematol, Oct. 2009, Refereed, Not invited
Corresponding - 17-168 関節リウマチの病態を修飾する二次性線維筋痛症(慢性疼痛2,一般演題(ポスター発表),近未来医療を担う心身医学,第1回日本心身医学5学会合同集会)
井上 幹紀親; 三浦 勝浩; 北村 登; 松川 吉博; 武井 正美; 村上 正人; 橋本 修; 澤田 滋正
心身医学, 2009 - Case reports: Arsenic trioxide is effective in relapsed acute promyelocytic leukemia followed by cyropreserved autologous stem cell transplantation.
Yujin Kobayashi; Sumiko Kobayashi; Hikari Ishizuka; Daisuke Kurita; Toshitake Tanaka; Katsuhiro Miura; Noriyoshi Iriyama; Kumi Uenogawa; Yoshihiro Hatta; Jin Takeuchi
Low Temp. Med., 2008, Refereed, Not invited - Durable molecular complete remission induced by low-dose imatinib plus low-dose interferon alpha in a patient with chronic myelogenous leukaemia
J. Takeuchi; K. Miura; Y. Hatta; U. Sawada
Journal of International Medical Research, 2006, Refereed, Not invited - 急性赤芽癆を契機に発見された染色体15q,9q転座を伴った頭蓋咽頭腫の1例
中山智祥; 井上 満; 熊坂一成; 竹内 仁; 三浦勝浩; 八幡貴治; 安倍久子; 上松瀬勝男; 國分眞一朗; 急性赤芽癆を契機に発見された; 転座を伴った頭蓋咽頭腫の; 例; 板橋区医師会医学
板橋区医師会医学会誌 8: 140-142, 2004.5, May 2004, Not refereed, Not invited
MISC
- 再発性/難治性DLBCL患者におけるifosfamide、etoposide、dexamethasone、中程度用量cytarabineを併用したrituximab(R-IDEA)療法に関する第II相研究(A phase II study of rituximab plus ifosfamide, etoposide, dexamethasone and intermediate dose cytarabine(R-IDEA) in patients with relapsed/refractory DL
前田 嘉信; 近藤 英生; 山本 和彦; 増成 太郎; 三浦 勝浩; 瀧澤 淳; 正木 康史; 村上 純; 富田 直人; 神野 正敏
日本リンパ網内系学会会誌, May 2018, Not refereed, Not invited - Clinical Significance of Co-Expression of MYC and BCL2 Protein in Advanced Diffuse Large B-Cell Lymphoma Treated with a Dose-Intensified Immunochemotherapy
Hiromichi Takahashi; Sumiko Kobayashi; Katsuhiro Miura; Daisuke Kurita; Yoshihiro Hatta; Masahiko Sugitani; Shimon Otake; Masaru Nakagawa; Masashi Sakagami; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Machiko Kusuda; Atsuko Hojo; Mai Yagi; Yukio Hirabayashi; Yujin Kobayashi; Tomohiro Nakayama; Masami Takei
BLOOD, Dec. 2015, Not refereed, Not invited - A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP
Katsuhiro Miura; Jun Konishi; Takaaki Miyake; Makita Masanori; Atsuko Hojo; Yasufumi Masaki; Masatoshi Uno; Jun Ozaki; Chikamasa Yoshida; Daigo Niiya; Koichi Kitazume; Yoshinobu Maeda; Jun Takizawa; Rika Sakai; Yuichiro Nawa; Tomofumi Yano; Kazuhiko Yamamoto; Kazutaka Sunami; Yasushi Hiramatsu; Kazutoshi Aoyama; Hideki Tsujimura; Yoshihiro Hatta; Masatoshi Kanno
BLOOD, Dec. 2015, Not refereed, Not invited - A clinical prediction model for infusion reaction to rituximab
Akihiro Uchiike; Tatsuya Hayama; Katsuhiro Miura; Daisuke Tsutsumi; Masatoshi Hayasaka; Yoshihiro Hatta; Masami Takei; Yoshikazu Yoshida
ANNALS OF ONCOLOGY, Nov. 2015, Not refereed, Not invited - Clinical Significance of Arbekacin Sulfate for High-Risk Infections Among Patients with Hematological Malignancies
Katsuhiro Miura; Satomi Kiso; Masaru Nakagawa; Hiromichi Takahashi; Yoshito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Masashi Sakagami; Shimon Ohtake; Sumiko Kobayashi; Atsuko Hojo; Mai Yagi; Daisuke Kurita; Yujin Kobayashi; Machiko Kusuda; Yukio Hirabayashi; Yoshihiro Hatta; Masami Takei
BLOOD, Dec. 2014, Not refereed, Not invited - Efficacy of a Dose-Intensified CHOP (Double-CHOP) Regimen for Peripheral T-Cell Lymphomas
Hiromichi Takahashi; Noriyoshi Iriyama; Yoshihiro Hatta; Katsuhiro Miura; Yujin Kobayashi; Daisuke Kurita; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Satomi Kiso; Yoshihito Uchino; Masaru Nakagawa; Machiko Kusuda; Sumiko Kobayashi; Akira Horikoshi; Yoshimasa Kura; Tetsuo Yamazaki; Umihiko Sawada; Jin Takeuchi
BLOOD, Nov. 2012, Not refereed, Not invited - Dose-Intensified CHOP with Rituximab (R-Double-CHOP) Followed by Consolidating High-Dose Chemotherapy Is An Effective Treatment for Younger Patients with Advanced Diffuse Large B-Cell Lymphoma
Daisuke Kurita; Katsuhiro Miura; Yoshihiro Hatta; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Satomi Kiso; Yujin Kobayashi; Toshitake Tanaka; Noriyoshi Iriyama; Sumiko Kobayashi; Kazuhiro Takei; Akira Horikoshi; Tetsuo Yamazaki; Yoshimasa Kura; Umihiko Sawada; Jin Takeuchi
BLOOD, Nov. 2011, Not refereed, Not invited - An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma (vol 94, pg 90, 2011)
Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Satomi Kiso; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Daisuke Kurita; Yujin Kobayashi; Toshitake Tanaka; Noriyoshi Iriyama; Yoshihiro Hatta; Yoshimasa Kura; Tetsuo Yamazaki; Umihiko Sawada; Jin Takeuchi
INTERNATIONAL JOURNAL OF HEMATOLOGY, Aug. 2011, Not refereed, Not invited - An Effective Salvage Treatment Using Rituximab, Ifosfamide, Etoposide, Cytarabine, and Dexamethasone (R-IVAD) for Patients with Relapsed or Refractory Aggressive B-Cell Lymphoma
Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Yujin Kobayashi; Toshitake Tanaka; Daisuke Kurita; Noriyoshi Iriyama; Yasuyuki Inoue; Yoshihiro Hatta; Yoshimasa Kura; Umihiko Sawada; Jin Takeuchi
BLOOD, Nov. 2010, Not refereed, Not invited - SERUM TOTAL PROTEIN LEVEL IS AN ALTERNATIVE PROGNOSTIC FACTOR AMONG ELDERLY PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
Katsuhiro Miura; Yujin Kobayashi; Atsuko Hojo; Yukio Hirabayashi; Masaru Nakagawa; Hikaru Ishizuka; Yoshihiro Hatta; Jin Takeuchi
ANNALS OF ONCOLOGY, Nov. 2010, Not refereed, Not invited - Obesity Is a Poor Prognostic Factor In Acute Promyelocytic Leukemia (APL)
Yoshihiro Hatta; Akira Horikoshi; Daisuke Kurita; Sumiko Kobayashi; Yujin Kobayashi; Yoshimasa Kura; Hitomi Kodaira; Yasuyuki Inoue; Katsuhiro Miura; Satomi Kiso; Hiromichi Takahashi; Hikari Ishizuka; Toshitake Tanaka; Mai Yagi; Atsuko Hojo; Yukio Hirabayashi; Yoshihito Uchino; Noriyoshi Iriyama; Umihiko Sawada; Jin Takeuchi
BLOOD, Nov. 2010, Not refereed, Not invited - Feasibility and eligibility of retreatment with rabbit anti-T lymphocyte globulin for aplastic anemia previously treated with horse anti-thymocyte globulin
Katsuhiro Miura; Yoshihiro Hatta; Sumiko Kobayashi; Yoshinori Iriyama; Kazuhiro Takei; Jin Takeuchi
International Journal of Hematology, Oct. 2009, Not refereed, Not invited - JALSG参加施設における感染症の予防・診断・治療の実態調査結果
藤田 浩之; 吉田 稔; 三浦 勝浩; 佐野 徹明; 松島 孝文; 木藤 克之; 高橋 正知; 重野 一幸; 神田 善伸; 秋山 暢; 宮脇 修一; 大西 一功; 直江 知樹
臨床血液, Sep. 2008, Not refereed, Not invited - 進行性多巣性白質脳症(PML)を発症した成人T細胞白血病(ATL)の1例
栗田 大輔; 藏 良政; 澤田 海彦; 三浦 勝浩; 石塚 光; 小林 寿美子; 八田 善弘; 竹内 仁
臨床血液, Sep. 2008, Not refereed, Not invited - Role of gemtuzumab ozogamicin in treatment of AML
三浦 勝浩; 竹内 仁
血液・腫瘍科, Aug. 2007 - AML治療におけるgemtuzumab ozogamicinの役割
三浦勝浩; 竹内仁
血液・腫瘍科, 2007, Not refereed, Invited
Lectures, oral presentations, etc.
- ★CONSOLIDATION THERAPY USING 90Y-IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRIZ2012)
The 24th Congress of the European Hematology Association, Jun. 2019, Not invited - ★Bendamustine and rituximab (BR) followed by 90Y-ibritumomab tiuxetan (90Y-IT) for relapsed follicular lymphoma; , a preliminary analysis of a multicenter, prospective phase II study (BRiZ 2012)
The ESMO 2018 Congress, Oct. 2018 - Consolidation therapy using 90Y-ibritumomab tiuxetan after bendamustine and rituximab in patients with relapsed follicular lymphoma; a multicenter, phase II study (BRiZ2012)
H. Tsujimura, K. Miura, M. Kanno, Y. Masaki, M. Iino, J. Takizawa, Y. Maeda, K. Yamamoto, S. Tamura, A. Yoshida, H. Yagi, I. Yoshida, K. Kitazume, T. Masunari, I. Choi, Y. Kakinoki, T. Yoshino, S. Nakamura, T. Yoshida
The 24th European Hematology Association congress, Jun. 2019, Not invited - Bendamustine and rituximab (BR) followed by 90Y-ibritumomab tiuxetan (90Y-IT) for relapsed follicular lymphoma; a preliminary analysis of a multicenter, prospective phase II study (BRiZ 2012)
M. Kanno, K. Miura, Y. Masaki, H. Tsujimura, M. Iino, J. Takizawa, Y. Maeda, K. Yamamoto, S. Tamura, A. Yoshida, H. Yagi, I. Yoshida, K. Kitazume, T. Masunari, I. Choi, Y. Kakinoki, T. Yoshino, S. Nakamura, T. Yoshida
European Society of Medical Oncology 2018 congress, Oct. 2018, Not invited - A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP
Katsuhiro Miura; Jun Konishi; Takaaki Miyake; Makita Masanori; Atsuko Hojo; Yasufumi Masaki; Masatoshi Uno; Jun Ozaki; Chikamasa Yoshida; Daigo Niiya; Koichi Kitazume; Yoshinobu Maeda; Jun Takizawa; Rika Sakai; Yuichiro Nawa; Tomofumi Yano; Kazuhiko Yamamoto; Kazutaka Sunami; Yasushi Hiramatsu; Kazutoshi Aoyama; Hideki Tsujimura; Yoshihiro Hatta and Masatoshi Kanno
57th annual meeting of the American Society of Hematology, Dec. 2015, Not invited - Clinical Significance of Co-Expression of MYC and BCL2 Protein in Advanced Diffuse Large B-Cell Lymphoma Treated with a Dose-Intensified Immunochemotherapy
Hiromichi Takahashi; Sumiko Kobayashi; Katsuhiro Miura; Daisuke Kurita; Yoshihiro Hatta; Masahiko Sugitani; Shimon Otake; Masaru Nakagawa; Masashi Sakagami; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Machiko Kusuda; Atsuko Hojo; Mai Yagi; Yukio Hirabayashi; Yujin Kobayashi; Tomohiro Nakayama and Masami Takei
57th annual meeting of the American Society of Hematology, Dec. 2015, Not invited - CLINICAL SIGNIFICANCE OF CO-EXPRESSION OF MYC AND BCL2 PROTEIN IN AGGRESSIVE B-CELL LYMPHOMAS TREATED WITH A SECOND LINE IMMUNOCHEMOTHERAPY
Katsuhiro Miura; Masaru Nakagawa; Hiromichi Takahash; Yoshihiro Hatta; Masahiko Sugitani; Shimon Otake; Masashi Sakagami; Yoshihito Uchino; Satomi Kiso; Hitomi Kodaira; Noriyoshi Iriyama; Sumiko Kobayashi; Atsuko Hojo; Mai Yagi; Daisuke Kurita; Yujin Kobayashi; Masami Takei
20th Congress of European Hematology Association, Jun. 2015, Not invited - . Clinical Significance of Arbekacin Sulfate for High-Risk Infections Among Patients with Hematological Malignancies
61.Katsuhiro Miura; Satomi Kiso; Masaru Nakagawa; Hiromichi Takahashi; Yoshito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; MD; Masashi Sakagami; Shimon Ohtake; Sumiko Kobayashi; Atsuko Hojo; Mai Yagi; Daisuke Kurita; Yujin Kobayashi; Machiko Kusuda; Yukio Hirabayashi; Yoshihiro Hatta; and Masami Take
56th annual meeting of the American Society of Hematology, Dec. 2014, Not invited - Dose-Intensified CHOP with Rituximab(R-Double-CHOP)followed by consolidating high dose chemotherapy is an effective treatment for younger patients with advanced Diffuse Large B-cell Lymphoma
52.Kurita D; Miura K; Hatta Y; Hirabayashi Y; Hojo A; Kodaira H; Yagi M; Kiso S; Iriyama N; Tanaka T; Kobayashi Y; Kobayashi S; Takei K; Horikoshi A; Yamazaki T; Kura Y; Sawada U; Takeuchi J
53nd Annual Meeting of the American Society of Hematology, Dec. 2011, Not invited - An Effective Salvage Treatment Using Rituximab, Ifosfamide, Etooside, Cytarabin and Dexamethasone (R-IVAD) for Patients with Relapsed or Refractory Aggressive B-Cell Lymphoma
45.Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Yujin Kobayashi; Toshitake Tanaka; Daisuke Kurita; Noriyoshi Iriyama; Yasuyuki Inoue; Yoshihiro Hatta; Yoshimasa Kura; Umihiko Sawada; Jin Takeuchi
52nd Annual Meeting of American Society of Hematology, Dec. 2010, Not invited
